Cargando…
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
BACKGROUND: Coronavirus disease 2019 is a pandemic with no specific therapeutic agents or vaccination. Small published case series on critically ill adults suggest improvements in clinical status with minimal adverse events when patients receive coronavirus disease 2019 convalescent plasma, but data...
Autores principales: | Schwartz, Stephanie P., Thompson, Peyton, Smith, Melissa, Lercher, Daniel M., Rimland, Casey A., Bartelt, Luther, Park, Yara A., Weiss, Susan, Markmann, Alena Janda, Raut, Rajendra, Premkumar, Lakshmanane, Kuruc, JoAnn, Willis, Zachary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531759/ https://www.ncbi.nlm.nih.gov/pubmed/33063037 http://dx.doi.org/10.1097/CCE.0000000000000237 |
Ejemplares similares
-
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021) -
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021) -
Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
por: Markmann, Alena J., et al.
Publicado: (2021) -
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
por: Bartelt, Luther A., et al.
Publicado: (2022) -
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
por: Root, Heather B., et al.
Publicado: (2022)